Concepedia

Publication | Open Access

The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study

34

Citations

56

References

2021

Year

References

YearCitations

Page 1